US HB2498 | 2019-2020 | 116th Congress

Status

Spectrum: Slight Partisan Bill (Democrat 22-11)
Status: Introduced on May 2 2019 - 25% progression, died in committee
Action: 2019-05-02 - Referred to the House Committee on Ways and Means.
Pending: House Ways And Means Committee
Text: Latest bill text (Introduced) [PDF]

Summary

Specifies that payment under Medicare to a hospital for the acquisition costs of an allogeneic hematopoietic stem cell transplant (e.g., bone marrow transplant from a donor) must be made on a reasonable cost basis (similar to the current payment methodology for solid organ acquisitions). The Centers for Medicare & Medicaid Services must determine included items through regulations.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

PACT Act Patient Access to Cellular Transplant Act

Sponsors


History

DateChamberAction
2019-05-02HouseReferred to the House Committee on Ways and Means.
2019-05-02HouseIntroduced in House

Same As/Similar To

SB1268 (Same As) 2019-05-01 - Read twice and referred to the Committee on Finance.
HB1865 (Related) 2019-12-20 - Became Public Law No: 116-94. (TXT | PDF)

Subjects


US Congress State Sources


Bill Comments

feedback